The FDA can make a difference in direct-to-consumer communications by working with the pharmaceutical industry, writes Peter Pitts, president of the Center for Medicine in the Public Interest and a former associate commissioner at the FDA. Both parties can transform DTC into a more persuasive, accurate and potent tool that will benefit public health, he writes.
Pharma-FDA collaboration can boost DTC as public health tool
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||